ACR sets date for cardiac CT proficiency exam
The American College of Radiology (ACR) will offer the first Cardiac CT Certificate of Advanced Proficiency Examination on Sept. 9. The college said it is open to all physicians who meet eligibility requirements and professional experience qualifications.
The exam will be offered quarterly, and administered at the ACR Education Center, a training and testing facility on the campus of the ACR headquarters in Reston, Va. It is a four-hour exam and contains both practical and case-based components, as well as a knowledge-based multiple choice section. The case-based component simulates a practice setting where candidates are able to conduct cardiac CT case assessments.
The ACR said that the goal in providing the exam is to assist members in documenting the additional training and expertise some institutions require in specific, highly specialized areas of radiology.
“This exam will allow physicians with considerable experience in cardiac CT to provide documentation to third-party payors, their institutions, and other stakeholders that they are proficient in this increasingly important area of medicine,” said ACR CEO Harvey L. Neiman, MD.
The exam will be offered quarterly, and administered at the ACR Education Center, a training and testing facility on the campus of the ACR headquarters in Reston, Va. It is a four-hour exam and contains both practical and case-based components, as well as a knowledge-based multiple choice section. The case-based component simulates a practice setting where candidates are able to conduct cardiac CT case assessments.
The ACR said that the goal in providing the exam is to assist members in documenting the additional training and expertise some institutions require in specific, highly specialized areas of radiology.
“This exam will allow physicians with considerable experience in cardiac CT to provide documentation to third-party payors, their institutions, and other stakeholders that they are proficient in this increasingly important area of medicine,” said ACR CEO Harvey L. Neiman, MD.